Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Other Working Capital Changes (2016 - 2025)

Conmed (CNMD) has disclosed Other Working Capital Changes for 16 consecutive years, with $225000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes fell 93.78% year-over-year to $225000.0, compared with a TTM value of $13.2 million through Dec 2025, down 5.4%, and an annual FY2025 reading of $13.2 million, down 5.4% over the prior year.
  • Other Working Capital Changes was $225000.0 for Q4 2025 at Conmed, down from $3.1 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $11.4 million in Q1 2023 and bottomed at -$133000.0 in Q4 2023.
  • Average Other Working Capital Changes over 5 years is $4.5 million, with a median of $4.9 million recorded in 2022.
  • Peak annual rise in Other Working Capital Changes hit 3027.64% in 2023, while the deepest fall reached 102.21% in 2023.
  • Year by year, Other Working Capital Changes stood at $8.1 million in 2021, then fell by 25.53% to $6.0 million in 2022, then plummeted by 102.21% to -$133000.0 in 2023, then surged by 2819.55% to $3.6 million in 2024, then plummeted by 93.78% to $225000.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for CNMD at $225000.0 in Q4 2025, $3.1 million in Q3 2025, and $4.5 million in Q2 2025.